annb0t
Top 20
Recce Pharmaceuticals
SYDNEY, Australia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce a total research and development (R&D) cash receipt of A$6,219,241.
âThe total cash amount of A$6,219,241 received from the R&D Tax Incentive Rebate and Radiumâs advanced payment is most welcomed and provides the Company with an important cash injection to contin...
>>> Read more: Recce Pharmaceuticals Receives A$6.21 Million from Research and Development (R&D) Rebate Payments
SYDNEY, Australia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce a total research and development (R&D) cash receipt of A$6,219,241.
âThe total cash amount of A$6,219,241 received from the R&D Tax Incentive Rebate and Radiumâs advanced payment is most welcomed and provides the Company with an important cash injection to contin...
>>> Read more: Recce Pharmaceuticals Receives A$6.21 Million from Research and Development (R&D) Rebate Payments
